Population
5 patients with repaired tetralogy of Fallot or its variants at risk for sudden arrhythmic death
Design
Case_series
Authors
Loading...
Clinical parameters and pharmacotherapy may underestimate SCD risk in repaired tetralogy of Fallot; leaves open the need for prospective trials on ablation and devices.
In patients with repaired tetralogy of Fallot, pharmacologic therapy alone is rarely adequate for preventing sudden cardiac death, highlighting the increasing role of catheter ablation and antitachycardia devices.
SAUL et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: